Q-omics provides the consensus-scored MIR95 profile across patient tissues and cancer cell-line models. MIR95 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, MIR95 is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, MIR95 RNA expression shows 10,068 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight UCS, THCA, and GBM as cancer lineages where MIR95 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR95 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR95 survival associations across molecular data types. MIR95 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR95 RNA expression–survival associations across cancer types. High MIR95 expression shows unfavorable associations in UCS, SKCM, MESO, ESCA and UCEC, but favorable associations in HNSC. The UCS Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for MIR95 RNA expression.
This table summarizes MIR95 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR95. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR95 shows lower tumor expression in THCA. The THCA box plot shows higher MIR95 RNA expression in normal versus tumor tissue (log2 FC = −0.308, t-test p = .003).
This table shows molecular features associated with MIR95 in patient tissues and cancer cell lines. In patient samples, MIR95 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
